| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 7.15e-05 | 32 | 140 | 4 | GO:0015106 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 9.16e-05 | 13 | 140 | 3 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 9.16e-05 | 13 | 140 | 3 | GO:0140829 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 2.13e-04 | 17 | 140 | 3 | GO:0008574 | |
| GeneOntologyMolecularFunction | protein kinase inhibitor activity | 2.63e-04 | 81 | 140 | 5 | GO:0004860 | |
| GeneOntologyMolecularFunction | kinase inhibitor activity | 3.48e-04 | 86 | 140 | 5 | GO:0019210 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDKN1A TRIB2 HK1 ATR SCYL1 CIT CASK STK10 DGKK TBCK PKLR MAP3K13 EIF2AK2 PLK4 | 4.68e-04 | 709 | 140 | 14 | GO:0016773 |
| Domain | CARMIL_C | 3.95e-07 | 3 | 138 | 3 | IPR031943 | |
| Domain | CARMIL_C | 3.95e-07 | 3 | 138 | 3 | PF16000 | |
| Domain | LRR_6 | 5.29e-05 | 55 | 138 | 5 | PF13516 | |
| Domain | ARM-type_fold | 2.16e-04 | 339 | 138 | 10 | IPR016024 | |
| Domain | Kinesin_motor_CS | 2.34e-04 | 41 | 138 | 4 | IPR019821 | |
| Domain | Kinesin-like_fam | 2.82e-04 | 43 | 138 | 4 | IPR027640 | |
| Domain | - | 3.08e-04 | 44 | 138 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 3.08e-04 | 44 | 138 | 4 | PF00225 | |
| Domain | KISc | 3.08e-04 | 44 | 138 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 3.08e-04 | 44 | 138 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 3.08e-04 | 44 | 138 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 3.08e-04 | 44 | 138 | 4 | PS50067 | |
| Domain | Anion_exchange | 5.34e-04 | 5 | 138 | 2 | IPR001717 | |
| Domain | Kinase-like_dom | TRIB2 ATR SCYL1 CIT CASK STK10 TBCK MACF1 MAP3K13 EIF2AK2 PLK4 SOS1 | 6.99e-04 | 542 | 138 | 12 | IPR011009 |
| Domain | GAR | 7.97e-04 | 6 | 138 | 2 | PS51460 | |
| Domain | GAS2 | 7.97e-04 | 6 | 138 | 2 | PF02187 | |
| Domain | - | 7.97e-04 | 6 | 138 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 7.97e-04 | 6 | 138 | 2 | IPR003108 | |
| Domain | GAS2 | 7.97e-04 | 6 | 138 | 2 | SM00243 | |
| Domain | ANION_EXCHANGER_2 | 1.11e-03 | 7 | 138 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 1.11e-03 | 7 | 138 | 2 | PS00219 | |
| Domain | - | 1.33e-03 | 222 | 138 | 7 | 1.25.10.10 | |
| Domain | - | 1.89e-03 | 9 | 138 | 2 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 1.89e-03 | 9 | 138 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 1.89e-03 | 9 | 138 | 2 | PF07565 | |
| Domain | Pkinase | 2.12e-03 | 381 | 138 | 9 | PF00069 | |
| Domain | PTrfase/Anion_transptr | 2.35e-03 | 10 | 138 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 2.35e-03 | 10 | 138 | 2 | IPR003020 | |
| Domain | HCO3_cotransp | 2.35e-03 | 10 | 138 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 2.35e-03 | 10 | 138 | 2 | IPR011531 | |
| Domain | - | 2.69e-03 | 321 | 138 | 8 | 3.80.10.10 | |
| Domain | L_dom-like | 3.06e-03 | 328 | 138 | 8 | IPR032675 | |
| Domain | ARM-like | 3.97e-03 | 270 | 138 | 7 | IPR011989 | |
| Domain | Leu-rich_rpt | 4.05e-03 | 271 | 138 | 7 | IPR001611 | |
| Domain | PH | 4.65e-03 | 278 | 138 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 4.74e-03 | 279 | 138 | 7 | PS50003 | |
| Domain | PH_domain | 4.83e-03 | 280 | 138 | 7 | IPR001849 | |
| Domain | WW | 5.05e-03 | 47 | 138 | 3 | PF00397 | |
| Domain | Sialyl_trans | 5.34e-03 | 15 | 138 | 2 | IPR012163 | |
| Domain | WW | 5.35e-03 | 48 | 138 | 3 | SM00456 | |
| Domain | HEAT | 5.35e-03 | 48 | 138 | 3 | PF02985 | |
| Domain | WW_DOMAIN_1 | 6.34e-03 | 51 | 138 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 6.34e-03 | 51 | 138 | 3 | PS50020 | |
| Domain | WW_dom | 6.70e-03 | 52 | 138 | 3 | IPR001202 | |
| Pubmed | STBD1 SENP3 LAMA5 HBP1 ZNF518A CASK METAP1 OPTN KIF3B NUP155 MCM3AP PLCL2 SECISBP2 MACF1 KIF13A SMURF2 | 2.98e-09 | 591 | 142 | 16 | 15231748 | |
| Pubmed | ABCF1 ATR SENP3 PARG ANKRD50 ANKHD1 INTS3 CLSTN1 NOP9 GTPBP2 NUP155 TUBGCP3 TANC1 MICU2 CLEC16A PALLD | 1.14e-08 | 650 | 142 | 16 | 38777146 | |
| Pubmed | USP34 HK1 CCDC30 WDR7 PPFIA1 SENP3 WRN SCYL1 CCT4 ANKRD50 CASK EFTUD2 GTPBP2 NUP155 PKLR AHSG CLEC16A | 2.16e-08 | 777 | 142 | 17 | 35844135 | |
| Pubmed | Cell Migration and Invadopodia Formation Require a Membrane-binding Domain of CARMIL2. | 6.66e-08 | 3 | 142 | 3 | 26578515 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | THOC1 ABCF1 ATR CARMIL1 PARG INTS3 SIRT1 TBC1D9 EFTUD2 FANCD2 STK10 WWC2 NF1 WDHD1 RIPOR1 SOS1 | 1.25e-07 | 774 | 142 | 16 | 15302935 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP34 ABCF1 HK1 RPLP1 PPFIA1 SCYL1 NCBP1 CCT4 TSEN2 SIRT1 LARP7 EFTUD2 FANCD2 OPTN NUP155 WDHD1 MACF1 RIPOR1 DCTN4 KIF13A PLOD2 | 5.06e-07 | 1455 | 142 | 21 | 22863883 |
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 19704162 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 19846667 | ||
| Pubmed | RALGAPA1 ABCF1 HK1 CAND2 STBD1 PPFIA1 MRPL44 CYP51A1 KIF16B SIRT1 LARP7 CASK EFTUD2 NUP155 TUBGCP3 MACF1 TANC1 PLOD2 ANKRD52 DNAJC3 VPS13B | 7.18e-07 | 1487 | 142 | 21 | 33957083 | |
| Pubmed | ETAA1 acts at stalled replication forks to maintain genome integrity. | 1.51e-06 | 21 | 142 | 4 | 27723720 | |
| Pubmed | RALGAPA1 ABCF1 HK1 CARMIL2 BTBD8 RPLP1 WDR7 CARMIL1 PPFIA1 CCT4 ARHGEF11 CIT SLC4A1 CASK NF1 SLC4A10 MACF1 TANC1 SSH2 DCTN4 | 1.59e-06 | 1431 | 142 | 20 | 37142655 | |
| Pubmed | RALGAPA1 USP34 CAND2 KIF16B LAMA5 ANKRD50 ANKHD1 METAP1 FBXL7 NUP155 SLIT3 ARHGAP20 | 1.97e-06 | 529 | 142 | 12 | 14621295 | |
| Pubmed | RPLP1 WDR7 SCYL1 NCBP1 NOL10 INTS3 CIT TSEN2 MCM3AP TUBGCP3 DCTN4 | 2.69e-06 | 451 | 142 | 11 | 30033366 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ABCF1 HK1 SENP3 CCT4 NOL10 ANKHD1 KIF20B EFTUD2 ACSL4 NF1 NUP155 MCM3AP TUBGCP3 MACF1 TANC1 DCTN4 ANKRD52 EIF2AK2 PALLD | 2.78e-06 | 1353 | 142 | 19 | 29467282 |
| Pubmed | USP34 ABCF1 HK1 RPLP1 NCBP1 NOL10 ANKHD1 LARP7 NF1 NUP155 MCM3AP MACF1 ANKRD52 | 3.05e-06 | 653 | 142 | 13 | 22586326 | |
| Pubmed | THOC1 ABCF1 NCBP1 ARHGEF11 CIT KRT80 CASK EFTUD2 METAP1 NUP155 MACF1 SSH2 EIF2AK2 | 3.42e-06 | 660 | 142 | 13 | 32780723 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ATR PPFIA1 SENP3 NCBP1 CCT4 INTS3 EFTUD2 FANCD2 NF1 NUP155 TUBGCP3 MACF1 | 5.21e-06 | 582 | 142 | 12 | 20467437 |
| Pubmed | RALGAPA1 ELP5 PPFIA1 NCBP1 CCT4 NOL10 CASK FANCD2 ACSL4 WWC2 NUP155 PLCL2 TANC1 SSH2 ANKRD52 PLK4 | 6.52e-06 | 1049 | 142 | 16 | 27880917 | |
| Pubmed | BTBD8 WDR7 KIAA0232 KIF3B MCM3AP PLCL2 MACF1 RIPOR1 CLEC16A VPS13B | 7.27e-06 | 407 | 142 | 10 | 12693553 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 CARMIL2 KIAA0232 CARMIL1 PPFIA1 WWC2 OPTN NF1 MACF1 TANC1 SSH2 KIF13A PLK4 PALLD | 1.26e-05 | 861 | 142 | 14 | 36931259 |
| Pubmed | USP34 PPFIA1 ANKHD1 SIRT1 LARP7 SLC4A1 ZNF518A FANCD2 GTPBP2 SH3TC1 MCM3AP TUBGCP3 MACF1 TANC1 ANKRD52 SOS1 | 1.40e-05 | 1116 | 142 | 16 | 31753913 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | TRIB2 CCT4 NOL10 ST3GAL5 DAW1 TBCK SLC4A10 CD302 EIF2AK2 PALLD | 1.48e-05 | 442 | 142 | 10 | 15815621 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | THOC1 ABCF1 MRPL44 SENP3 WRN NCBP1 NOL10 KIF20B LARP7 NOP9 NUP155 MACF1 EIF2AK2 | 1.52e-05 | 759 | 142 | 13 | 35915203 |
| Pubmed | 1.64e-05 | 130 | 142 | 6 | 12421765 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 35751457 | ||
| Pubmed | ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth. | 1.66e-05 | 2 | 142 | 2 | 25483783 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 12629512 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 17898070 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 30890607 | ||
| Pubmed | Sirtuin-mediated deacetylation pathway stabilizes Werner syndrome protein. | 1.66e-05 | 2 | 142 | 2 | 18588880 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 25388786 | ||
| Pubmed | BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer. | 1.66e-05 | 2 | 142 | 2 | 25736055 | |
| Pubmed | Nucleoporin Nup155 is part of the p53 network in liver cancer. | 1.66e-05 | 2 | 142 | 2 | 31089132 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 16127665 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 37937491 | ||
| Pubmed | Regulation of two renal chloride transporters, AE1 and pendrin, by electrolytes and aldosterone. | 1.66e-05 | 2 | 142 | 2 | 23383138 | |
| Pubmed | ATR controls the p21(WAF1/Cip1) protein up-regulation and apoptosis in response to low UV fluences. | 1.66e-05 | 2 | 142 | 2 | 21976111 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 25801465 | ||
| Pubmed | Sirt1-inducible deacetylation of p21 promotes cardiomyocyte proliferation. | 1.66e-05 | 2 | 142 | 2 | 31881009 | |
| Pubmed | WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells. | 1.66e-05 | 2 | 142 | 2 | 34772932 | |
| Pubmed | Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p. | 1.66e-05 | 2 | 142 | 2 | 7581463 | |
| Pubmed | ATR couples FANCD2 monoubiquitination to the DNA-damage response. | 1.66e-05 | 2 | 142 | 2 | 15314022 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 11239453 | ||
| Pubmed | Human kidney anion exchanger 1 interacts with kinesin family member 3B (KIF3B). | 1.66e-05 | 2 | 142 | 2 | 21871436 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | PPFIA1 NCBP1 ANKHD1 SIRT1 LARP7 FANCD2 GTPBP2 NUP155 EIF2AK2 | 2.01e-05 | 364 | 142 | 9 | 24778252 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | THOC1 ABCF1 HK1 RPLP1 ATR MRPL44 NCBP1 CCT4 NOL10 ANKHD1 LARP7 EFTUD2 FANCD2 NOP9 NF1 NUP155 GALNT5 EIF2AK2 | 2.16e-05 | 1425 | 142 | 18 | 30948266 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 2.28e-05 | 370 | 142 | 9 | 22922362 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | RALGAPA1 CARMIL2 CARMIL1 PPFIA1 KIF16B CASK STK10 OPTN NF1 TANC1 VPS13B | 2.36e-05 | 569 | 142 | 11 | 30639242 |
| Pubmed | ABCF1 CARMIL2 CNST CYP51A1 SCYL1 CIT ITGB7 EFTUD2 ACSL4 KIF3B NF1 NUP155 TUBGCP3 CD302 EIF2AK2 DNAJC3 | 2.44e-05 | 1168 | 142 | 16 | 19946888 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 ZGRF1 KIF20B SIRT1 BRCA2 PLA2G12A MCM3AP SECISBP2 MACF1 TANC1 ANKRD52 | 3.19e-05 | 588 | 142 | 11 | 38580884 |
| Pubmed | 3.59e-05 | 16 | 142 | 3 | 27760317 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 KIZ KIAA0232 CARMIL1 INTS3 TSEN2 CASK STK10 SH3TC1 GALNT11 TBCK MACF1 RIPOR1 TANC1 CLEC16A DNAJC3 SMURF2 VPS13B | 3.83e-05 | 1489 | 142 | 18 | 28611215 |
| Pubmed | 3.95e-05 | 496 | 142 | 10 | 31343991 | ||
| Pubmed | ABCF1 PPFIA1 SENP3 WRN LAMA5 CCT4 NOL10 ANKHD1 ARHGEF11 CIT KIF20B LARP7 CASK METAP1 MACF1 TANC1 MICU2 EIF2AK2 | 4.11e-05 | 1497 | 142 | 18 | 31527615 | |
| Pubmed | WDR7 NHSL2 PPFIA1 SENP3 CCT4 ARHGEF11 CIT CASK EFTUD2 FRY KIF3B NF1 MACF1 SSH2 | 4.28e-05 | 963 | 142 | 14 | 28671696 | |
| Pubmed | RALGAPA1 STBD1 WDR7 CYP51A1 KIF16B ANKRD50 ACSL4 NUP155 DCTN4 VPS13B | 4.51e-05 | 504 | 142 | 10 | 34432599 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 4.65e-05 | 313 | 142 | 8 | 38270169 | |
| Pubmed | 4.84e-05 | 231 | 142 | 7 | 21048031 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 15671039 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 27650558 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 22159421 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 35777810 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 8188688 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 19861535 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 20006588 | ||
| Pubmed | Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma. | 4.95e-05 | 3 | 142 | 2 | 25664850 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 29030114 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 11353515 | ||
| Pubmed | Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair. | 4.95e-05 | 3 | 142 | 2 | 25642963 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 18203716 | ||
| Pubmed | Neurofibromatosis with male breast cancer--risk factor or co-incidence? Report of two rare cases. | 4.95e-05 | 3 | 142 | 2 | 25267367 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 11356864 | ||
| Pubmed | Remodeling of Interstrand Crosslink Proximal Replisomes Is Dependent on ATR, FANCM, and FANCD2. | 4.95e-05 | 3 | 142 | 2 | 31067464 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 17203969 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 25557355 | ||
| Pubmed | Mechanism of RAD51-dependent DNA interstrand cross-link repair. | 4.95e-05 | 3 | 142 | 2 | 21719678 | |
| Pubmed | Expression and localization of Werner syndrome protein is modulated by SIRT1 and PML. | 4.95e-05 | 3 | 142 | 2 | 17996922 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 27819671 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 24672057 | ||
| Pubmed | Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. | 4.95e-05 | 3 | 142 | 2 | 16943440 | |
| Pubmed | Regulation of the Fanconi Anemia DNA Repair Pathway by Phosphorylation and Monoubiquitination. | 4.95e-05 | 3 | 142 | 2 | 34828369 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 25972512 | ||
| Pubmed | The Fanconi Anemia Pathway Protects Genome Integrity from R-loops. | 4.95e-05 | 3 | 142 | 2 | 26584049 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 21995812 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 8576172 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 30541550 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 28684355 | ||
| Pubmed | Effects of mesenchymal stem cell-derived exosomes on oxidative stress responses in skin cells. | 4.95e-05 | 3 | 142 | 2 | 34145535 | |
| Pubmed | Tumorigenic effect of nonfunctional p53 or p21 in mice mutant in the Werner syndrome helicase. | 4.95e-05 | 3 | 142 | 2 | 11280729 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 27264184 | ||
| Pubmed | Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. | 4.95e-05 | 3 | 142 | 2 | 12893777 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 9133444 | ||
| Pubmed | Differential B cell expression of mouse Fc receptor homologs. | 4.95e-05 | 3 | 142 | 2 | 15302849 | |
| Pubmed | Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus. | 5.09e-05 | 159 | 142 | 6 | 34578187 | |
| Pubmed | Architectural niche organization by LHX2 is linked to hair follicle stem cell function. | 5.20e-05 | 18 | 142 | 3 | 24012369 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | CMTR1 SENP3 PARG ANKHD1 INTS3 CREB5 LARP7 ACSL4 NOP9 WDHD1 SH3TC1 PLOD2 ANKRD52 | 5.30e-05 | 857 | 142 | 13 | 25609649 |
| Pubmed | 7.03e-05 | 104 | 142 | 5 | 9205841 | ||
| Pubmed | 7.35e-05 | 105 | 142 | 5 | 9628581 | ||
| Pubmed | 7.38e-05 | 170 | 142 | 6 | 15057823 | ||
| Pubmed | Programmed cell senescence during mammalian embryonic development. | 8.40e-05 | 21 | 142 | 3 | 24238962 | |
| Interaction | CDC5L interactions | THOC1 CDKN1A CMTR1 ATR PPFIA1 SENP3 WRN CCT4 INTS3 CIT LARP7 EFTUD2 FANCD2 NF1 NUP155 TUBGCP3 MACF1 MAP3K13 EIF2AK2 | 8.26e-06 | 855 | 141 | 19 | int:CDC5L |
| Interaction | HELQ interactions | 1.02e-05 | 20 | 141 | 4 | int:HELQ | |
| Interaction | RAC1 interactions | RALGAPA1 CARMIL2 CARMIL1 PPFIA1 ARHGEF11 CIT CASK FANCD2 STK10 OPTN NF1 NUP155 MCM3AP KRT40 MACF1 TANC1 ARHGAP20 PLOD2 EIF2AK2 SMURF2 SOS1 | 1.59e-05 | 1063 | 141 | 21 | int:RAC1 |
| Cytoband | 2q24.2 | 4.27e-05 | 22 | 142 | 3 | 2q24.2 | |
| Cytoband | 3p25.2 | 5.13e-04 | 11 | 142 | 2 | 3p25.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 6.75e-04 | 127 | 142 | 4 | chr2q24 | |
| Cytoband | 13q32.1 | 1.11e-03 | 16 | 142 | 2 | 13q32.1 | |
| Cytoband | 4q25 | 1.20e-03 | 67 | 142 | 3 | 4q25 | |
| Cytoband | 17q21.2 | 1.36e-03 | 70 | 142 | 3 | 17q21.2 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 9.07e-05 | 46 | 93 | 4 | 622 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 ATR WDR7 PPFIA1 PARG WRN KIF20B CREB5 CASK ACSL4 STK10 FBXL7 WDHD1 BRCA2 ST3GAL5 TUBGCP3 MACF1 MICU2 PLOD2 CLEC16A SMURF2 VPS13B SOS1 | 2.35e-10 | 856 | 142 | 23 | M4500 |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 5.86e-08 | 97 | 142 | 8 | M14698 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.46e-06 | 199 | 142 | 9 | M5893 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ATR PPFIA1 KIF16B WRN ZNF302 ANKHD1 KIF20B TBC1D9 LARP7 OPTN WDHD1 MICU2 POLQ DNAJC3 PALLD | 2.94e-06 | 656 | 142 | 15 | M18979 |
| Coexpression | FISCHER_DREAM_TARGETS | THOC1 ELP5 ZGRF1 RTTN CYP51A1 WRN NCBP1 CIT KIF20B LARP7 ZNF518A FANCD2 GTPBP2 NUP155 WDHD1 BRCA2 POLQ PLK4 | 5.31e-06 | 969 | 142 | 18 | M149 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | THOC1 COL6A3 ATR SNHG12 ZGRF1 WRN NCBP1 CCT4 FAM200A F2R KIF20B CASK ACSL4 NTAN1 NF1 NUP155 WDHD1 BRCA2 GALNT11 POLQ EIF2AK2 PLK4 | 7.10e-06 | 1407 | 142 | 22 | M14427 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ATR WDR7 PPFIA1 PARG WRN KIF20B CASK FBXL7 TUBGCP3 CLEC16A SMURF2 SOS1 | 9.36e-06 | 466 | 142 | 12 | M13522 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | CDKN1A ZGRF1 CIT KIF20B FANCD2 NUP155 WDHD1 BRCA2 POLQ EIF2AK2 PLK4 | 1.28e-05 | 402 | 142 | 11 | MM454 |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 1.30e-05 | 198 | 142 | 8 | M7610 | |
| Coexpression | GSE27786_NEUTROPHIL_VS_MONO_MAC_DN | 1.35e-05 | 199 | 142 | 8 | M4883 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 2.07e-05 | 153 | 142 | 7 | M5588 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 2.25e-05 | 155 | 142 | 7 | MM1259 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_UP | 3.49e-05 | 166 | 142 | 7 | M6688 | |
| Coexpression | MARKEY_RB1_CHRONIC_LOF_UP | 3.75e-05 | 114 | 142 | 6 | M2895 | |
| Coexpression | MARKEY_RB1_CHRONIC_LOF_UP | 4.14e-05 | 116 | 142 | 6 | MM1090 | |
| Coexpression | ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP | 4.55e-05 | 173 | 142 | 7 | M2480 | |
| Coexpression | GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP | 5.07e-05 | 176 | 142 | 7 | M5663 | |
| Coexpression | BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE | 6.68e-05 | 78 | 142 | 5 | M2532 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | ATR PARG WRN NCBP1 CCT4 KIF20B LARP7 METAP1 NF1 WDHD1 BRCA2 TUBGCP3 TGDS PLK4 | 6.99e-05 | 761 | 142 | 14 | M11961 |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 9.35e-05 | 194 | 142 | 7 | M7467 | |
| Coexpression | GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_UP | 9.97e-05 | 196 | 142 | 7 | M7666 | |
| Coexpression | GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_DN | 1.04e-04 | 137 | 142 | 6 | M8915 | |
| Coexpression | GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN | 1.06e-04 | 198 | 142 | 7 | M3325 | |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_UP | 1.06e-04 | 198 | 142 | 7 | M6168 | |
| Coexpression | NOUZOVA_TRETINOIN_AND_H4_ACETYLATION | 1.09e-04 | 138 | 142 | 6 | M15068 | |
| Coexpression | GSE42724_B1_BCELL_VS_PLASMABLAST_UP | 1.10e-04 | 199 | 142 | 7 | M9787 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BASOPHIL_DN | 1.10e-04 | 199 | 142 | 7 | M5414 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 1.10e-04 | 199 | 142 | 7 | M3070 | |
| Coexpression | GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN | 1.13e-04 | 200 | 142 | 7 | M8069 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_UP | 1.13e-04 | 200 | 142 | 7 | M9640 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN | 1.13e-04 | 200 | 142 | 7 | M3893 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_DN | 1.13e-04 | 200 | 142 | 7 | M7717 | |
| Coexpression | GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP | 1.13e-04 | 200 | 142 | 7 | M3142 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 1.28e-04 | 432 | 142 | 10 | MM419 | |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | TRIB2 CAND2 KIAA0232 CYP51A1 F2R FRY OPTN PLOD2 CLEC16A PALLD | 1.41e-04 | 437 | 142 | 10 | M4665 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | USP34 ATR SNHG12 NCBP1 ANKHD1 KIF20B CREB5 KRT80 GTPBP2 WDHD1 BRCA2 TUBGCP3 PLK4 | 1.56e-04 | 721 | 142 | 13 | M10237 |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | TRIB2 HK1 CCT4 SLC39A8 ACSL4 WWC2 PLA2G12A MACF1 MAP3K13 PLOD2 | 1.60e-04 | 444 | 142 | 10 | M41713 |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 2.05e-04 | 155 | 142 | 6 | M39041 | |
| Coexpression | RIGGINS_TAMOXIFEN_RESISTANCE_DN | 2.09e-04 | 221 | 142 | 7 | M15835 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN | 2.43e-04 | 160 | 142 | 6 | M8664 | |
| Coexpression | XIE_ST_HSC_S1PR3_OE_DN | 2.55e-04 | 23 | 142 | 3 | M41756 | |
| Coexpression | ACEVEDO_LIVER_CANCER_UP | USP34 RPLP1 MRPL44 CYP51A1 HBP1 SLC39A8 LARP7 CASK NTAN1 KRT222 TBCK PLCL2 DCTN4 MICU2 PALLD | 2.64e-04 | 972 | 142 | 15 | M15709 |
| CoexpressionAtlas | Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2 | TRIB2 SNHG12 ZGRF1 KIF20B FANCD2 OPTN WDHD1 BRCA2 ST3GAL5 PLA2G12A PKLR POLQ PLK4 | 1.90e-06 | 401 | 136 | 13 | GSM791108_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CDKN1A RALGAPA1 ABCF1 APCDD1 KIZ PPFIA1 NCBP1 ANKHD1 CIT KIF20B ZNF518A EIF4E1B ACSL4 NTAN1 BRCA2 DCTN4 POLQ | 2.37e-05 | 831 | 136 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ABCF1 APCDD1 PARG NCBP1 CIT KIF20B LARP7 ZNF518A ACSL4 NUP155 BRCA2 POLQ PLK4 | 3.87e-05 | 532 | 136 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.21e-05 | 204 | 136 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.56e-05 | 266 | 136 | 9 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.36e-08 | 195 | 142 | 9 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.36e-08 | 195 | 142 | 9 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.36e-08 | 195 | 142 | 9 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.42e-08 | 196 | 142 | 9 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.81e-07 | 190 | 142 | 8 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.04e-07 | 193 | 142 | 8 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.20e-07 | 195 | 142 | 8 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.29e-07 | 196 | 142 | 8 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.29e-07 | 196 | 142 | 8 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.29e-07 | 196 | 142 | 8 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.38e-07 | 197 | 142 | 8 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.67e-07 | 200 | 142 | 8 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-06 | 171 | 142 | 7 | f21eae4dd2e0a566eff792d19367e96ffb0b74ba | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-06 | 171 | 142 | 7 | d428c2859a1efc284610ca241a6dae9f182309cd | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-06 | 180 | 142 | 7 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 2.21e-06 | 185 | 142 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-06 | 187 | 142 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-06 | 187 | 142 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-06 | 189 | 142 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.64e-06 | 190 | 142 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.73e-06 | 191 | 142 | 7 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.92e-06 | 193 | 142 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.92e-06 | 193 | 142 | 7 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.02e-06 | 194 | 142 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.02e-06 | 194 | 142 | 7 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.13e-06 | 195 | 142 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.13e-06 | 195 | 142 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.24e-06 | 196 | 142 | 7 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.24e-06 | 196 | 142 | 7 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.24e-06 | 196 | 142 | 7 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.35e-06 | 197 | 142 | 7 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.46e-06 | 198 | 142 | 7 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 3.46e-06 | 198 | 142 | 7 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 3.46e-06 | 198 | 142 | 7 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.46e-06 | 198 | 142 | 7 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.46e-06 | 198 | 142 | 7 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.58e-06 | 199 | 142 | 7 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.58e-06 | 199 | 142 | 7 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.58e-06 | 199 | 142 | 7 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 3.58e-06 | 199 | 142 | 7 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.58e-06 | 199 | 142 | 7 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | Transverse-(2)_B_cell-(24)_B_cell_cycling|Transverse / shred on region, Cell_type, and subtype | 3.70e-06 | 200 | 142 | 7 | e3f9736227151f23f0e331eec0a7a15ce464b517 | |
| ToppCell | Transverse-B_cell-B_cell_cycling|Transverse / Region, Cell class and subclass | 3.70e-06 | 200 | 142 | 7 | 0e270f8019d9f22068ca426d661937262a5cd331 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.70e-06 | 200 | 142 | 7 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.93e-06 | 144 | 142 | 6 | 1c001a5a3bbe4ecbce8305f8b260e933033550dd | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-05 | 163 | 142 | 6 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-05 | 169 | 142 | 6 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 171 | 142 | 6 | a31c23406cf6d6a17358a8fb41d392a7fb0306e0 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 171 | 142 | 6 | 43d8fd9b9546e84a652564fe96b514b34b06262b | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 173 | 142 | 6 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-05 | 175 | 142 | 6 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Primitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.17e-05 | 176 | 142 | 6 | 664a7d15563428d0ae156d97aa88415fd0a0506a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-05 | 179 | 142 | 6 | 948c2a01ec7a626c68281e6e796a9f0527a88591 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 179 | 142 | 6 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 179 | 142 | 6 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.38e-05 | 179 | 142 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 180 | 142 | 6 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 180 | 142 | 6 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-05 | 185 | 142 | 6 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.05e-05 | 187 | 142 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 3.05e-05 | 187 | 142 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.05e-05 | 187 | 142 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 187 | 142 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 3.05e-05 | 187 | 142 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 189 | 142 | 6 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.23e-05 | 189 | 142 | 6 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.33e-05 | 190 | 142 | 6 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.43e-05 | 191 | 142 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.43e-05 | 191 | 142 | 6 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.43e-05 | 191 | 142 | 6 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.43e-05 | 191 | 142 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.53e-05 | 192 | 142 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.53e-05 | 192 | 142 | 6 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.53e-05 | 116 | 142 | 5 | f2bf9599040f43b5ea8724841d7b71c0a859c016 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.64e-05 | 193 | 142 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.64e-05 | 193 | 142 | 6 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.74e-05 | 194 | 142 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | Control-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type | 3.74e-05 | 194 | 142 | 6 | 844731b7943d1cfca819b7b89e4e62067bfa0230 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.74e-05 | 194 | 142 | 6 | f2f7b9aad7588c8020a4850ff9333e1db8eafac7 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.85e-05 | 195 | 142 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 196 | 142 | 6 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 4.08e-05 | 197 | 142 | 6 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.08e-05 | 197 | 142 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.08e-05 | 197 | 142 | 6 | fd7bdfa6bf5966ebc11fdd13915769429540ddbf | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 4.08e-05 | 197 | 142 | 6 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 4.08e-05 | 197 | 142 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-05 | 197 | 142 | 6 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.08e-05 | 197 | 142 | 6 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.19e-05 | 198 | 142 | 6 | 2b0716e900bce54ad1825d6dcdaf4ebf31f355c4 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 4.19e-05 | 198 | 142 | 6 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.19e-05 | 198 | 142 | 6 | dada1c19a261c8e1090957cd7e37f2a43a9fe14f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.19e-05 | 198 | 142 | 6 | d5e125f0c4f41b47d567568d0838adcca7655f6d | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.31e-05 | 199 | 142 | 6 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.31e-05 | 199 | 142 | 6 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.31e-05 | 199 | 142 | 6 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.31e-05 | 199 | 142 | 6 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.31e-05 | 199 | 142 | 6 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.31e-05 | 199 | 142 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.31e-05 | 199 | 142 | 6 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.31e-05 | 199 | 142 | 6 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 | |
| Disease | Intellectual Disability | RALGAPA1 ZNF142 HK1 RTTN UROC1 TSEN2 LARP7 FRY GTPBP2 NF1 ST3GAL5 SLC4A10 MACF1 | 1.98e-07 | 447 | 138 | 13 | C3714756 |
| Disease | Primary microcephaly | 3.14e-06 | 22 | 138 | 4 | C0431350 | |
| Disease | Profound Mental Retardation | 5.06e-05 | 139 | 138 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 5.06e-05 | 139 | 138 | 6 | C0025363 | |
| Disease | Mental deficiency | 5.06e-05 | 139 | 138 | 6 | C0917816 | |
| Disease | neuroimaging measurement, brain volume measurement | 6.32e-05 | 286 | 138 | 8 | EFO_0004346, EFO_0006930 | |
| Disease | Paroxysmal atrial fibrillation | 9.59e-05 | 156 | 138 | 6 | C0235480 | |
| Disease | familial atrial fibrillation | 9.59e-05 | 156 | 138 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 9.59e-05 | 156 | 138 | 6 | C2585653 | |
| Disease | Atrial Fibrillation | 1.10e-04 | 160 | 138 | 6 | C0004238 | |
| Disease | calcium measurement | CASR HBP1 F2R CREB5 SLC39A8 SLC4A1 METAP1 AHSG MACF1 POLQ SOS1 | 1.87e-04 | 628 | 138 | 11 | EFO_0004838 |
| Disease | congenital nonspherocytic hemolytic anemia (is_implicated_in) | 2.15e-04 | 5 | 138 | 2 | DOID:2861 (is_implicated_in) | |
| Disease | cardiovascular disease biomarker measurement | 3.22e-04 | 6 | 138 | 2 | EFO_0005278 | |
| Disease | atrial fibrillation | 3.72e-04 | 371 | 138 | 8 | EFO_0000275 | |
| Disease | Severe Congenital Microcephaly | 4.09e-04 | 31 | 138 | 3 | C3853041 | |
| Disease | Visual Impairment | 4.49e-04 | 7 | 138 | 2 | C3665347 | |
| Disease | Microlissencephaly | 4.93e-04 | 33 | 138 | 3 | C1956147 | |
| Disease | white matter microstructure measurement | 5.17e-04 | 390 | 138 | 8 | EFO_0005674 | |
| Disease | Pancreatic carcinoma, familial | 7.65e-04 | 9 | 138 | 2 | C2931038 | |
| Disease | red blood cell density measurement | RALGAPA1 TRIB2 HK1 ATR ARHGEF11 KIF20B SLC39A8 WWC2 ST3GAL5 PLCL2 SSH2 VPS13B | 9.04e-04 | 880 | 138 | 12 | EFO_0007978 |
| Disease | Fanconi anemia (is_implicated_in) | 9.53e-04 | 10 | 138 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | high grade glioma (is_implicated_in) | 1.01e-03 | 42 | 138 | 3 | DOID:3070 (is_implicated_in) | |
| Disease | aspartate aminotransferase measurement | CDKN1A BTBD8 CARMIL1 KIF16B SLC39A8 METAP1 WWC2 NF1 SH3TC1 CLEC16A EIF2AK2 SOS1 | 1.14e-03 | 904 | 138 | 12 | EFO_0004736 |
| Disease | Enzymopathy | 1.16e-03 | 11 | 138 | 2 | C0520572 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.25e-03 | 447 | 138 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Congenital pontocerebellar hypoplasia | 1.64e-03 | 13 | 138 | 2 | C0266468 | |
| Disease | renal sinus adipose tissue measurement | 1.64e-03 | 13 | 138 | 2 | EFO_0004864 | |
| Disease | FEV/FEC ratio | USP34 COL6A3 KIAA0232 TSEN2 WWC2 KIF3B TBCK RIPOR1 SSH2 ARHGAP20 KIF13A CLEC16A SMURF2 HDC | 1.89e-03 | 1228 | 138 | 14 | EFO_0004713 |
| Disease | Fanconi anemia | 1.90e-03 | 14 | 138 | 2 | cv:C0015625 | |
| Disease | RASopathy | 2.19e-03 | 15 | 138 | 2 | cv:C5555857 | |
| Disease | anemia (implicated_via_orthology) | 2.19e-03 | 15 | 138 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | theta wave measurement | 2.82e-03 | 17 | 138 | 2 | EFO_0006873 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.89e-03 | 206 | 138 | 5 | C0152013 | |
| Disease | Bone marrow hypocellularity | 3.16e-03 | 18 | 138 | 2 | C1855710 | |
| Disease | Hypertrophy | 3.16e-03 | 18 | 138 | 2 | C0020564 | |
| Disease | Liver Cirrhosis, Experimental | CDKN1A F2R SIRT1 SLC39A8 TBC1D9 STK10 FRY PLA2G12A PKLR PLOD2 | 3.55e-03 | 774 | 138 | 10 | C0023893 |
| Disease | lymphocyte count | TRIB2 CARMIL2 KIAA0232 SLC26A4 PPFIA1 UROC1 ARHGEF11 CLSTN1 ITGB7 SLC4A1 ST3GAL5 MCM3AP RIPOR1 SSH2 CLEC16A | 3.61e-03 | 1464 | 138 | 15 | EFO_0004587 |
| Disease | Microcephaly | 3.85e-03 | 67 | 138 | 3 | C0025958 | |
| Disease | atherosclerosis (biomarker_via_orthology) | 3.90e-03 | 20 | 138 | 2 | DOID:1936 (biomarker_via_orthology) | |
| Disease | intrinsic cardiomyopathy (implicated_via_orthology) | 4.30e-03 | 21 | 138 | 2 | DOID:0060036 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LAHVLELTAEISCFT | 321 | O60488 | |
| LLIVSHDQGFLDDVC | 501 | Q8NE71 | |
| AEEDHVDLSLSCTLV | 106 | P38936 | |
| ELLHSLEGFLDCSLV | 306 | P02730 | |
| LEDEIIFITCHEGSL | 756 | P41180 | |
| HLEELVLETCSLRGD | 246 | Q6F5E8 | |
| DEDLVDTCAFLHIKT | 121 | Q8IX05 | |
| HLLELSDTALSLEDC | 1211 | Q7Z2Y8 | |
| TICSVFEAEIVLLFH | 501 | Q9BX10 | |
| GFCTDTLLPHLLEDD | 686 | O15085 | |
| VSLLIDRGAEVDHCD | 731 | Q9ULJ7 | |
| ESLVSEEIVHDLDTC | 706 | O94985 | |
| VDCVHLLLEKGSTAD | 701 | Q8NB46 | |
| GDHELSLSEVRECLK | 236 | Q13217 | |
| HITGLDLFTELENCL | 181 | Q8TCP9 | |
| EEFELCLPDGDVSIH | 1491 | O14578 | |
| IVLHGLDLESEHCIF | 491 | Q96L93 | |
| HEEICLGLFTLILTE | 86 | Q68E01 | |
| EVGLFSELDCSLEHE | 71 | Q02930 | |
| HLETLLDPVDDCFSE | 541 | P19113 | |
| ACETTVELLFDSVIH | 151 | Q9BZM1 | |
| LDSLEEIHALTDCSE | 351 | O14936 | |
| ALSLSHCELITDDGI | 316 | Q9UKC9 | |
| LEERVHLECDGETIS | 911 | Q5KSL6 | |
| ELVLGLAAEVCDDFL | 181 | Q86U38 | |
| AACLAELLDSDELHV | 116 | A6NCF5 | |
| DISSLHGILEELTLC | 191 | Q6A162 | |
| QFEHTLLVTDTGCEI | 356 | P53582 | |
| ETEDHLESLICKVGE | 26 | Q09161 | |
| LTECHFVELTEDIGP | 366 | Q9GZQ4 | |
| LETLLCLIGESFEEH | 156 | A6NMX2 | |
| DVCAHLVDLFLVEEI | 1211 | O60318 | |
| DSRCHIDLSGIVEEV | 241 | Q6KB66 | |
| LVHLDLSGTDCVIDL | 366 | Q8ND23 | |
| EALTFEGATVTLHCE | 481 | Q96RD9 | |
| EAVEELSESVHGLCI | 436 | Q92628 | |
| FDLHLAATDEGCLET | 251 | Q8N1A0 | |
| FTEVLDHNECLIITG | 771 | Q86W56 | |
| ATGEVLVFLDSHCEV | 236 | Q8NCW6 | |
| SEKELESEGCVHILD | 71 | Q96Q89 | |
| VATLTGHDDEILDSC | 296 | Q8N136 | |
| LERCSLLEEELGATH | 186 | Q13136 | |
| VLYVDLLEGDTECHA | 481 | Q4G0J3 | |
| ADTFLEHLCLLDIDS | 66 | P30613 | |
| HEVFLDTIISRCLLD | 751 | Q96CW5 | |
| CEGQALLDVTHSELT | 1346 | O15230 | |
| FTSLEPEHDLNDVCL | 306 | Q9BSC4 | |
| SVLSEEEQTHCLEIG | 241 | Q2M2Z5 | |
| ELACIYSALILHDDE | 6 | P05386 | |
| GEELFDHIVSCISDF | 571 | P19367 | |
| STAHIDTEDSCGILL | 231 | Q969R2 | |
| DTLEHLVTELSSCGF | 4276 | Q9UPN3 | |
| ISSIAADGEFLHELE | 1131 | O75694 | |
| LCEFDTVDLSAVDVH | 281 | O00469 | |
| GFSEELIVELHTLCD | 461 | P26010 | |
| ITTCHDVLNETLLEG | 251 | P25116 | |
| LHTLIIAEAFEDDTG | 326 | Q8WX93 | |
| KSEGTCIHRLDEELI | 441 | O43283 | |
| ILFDSLTGECVHVDF | 2481 | Q13535 | |
| DLITCIELIEHLDSG | 126 | Q5T8I9 | |
| TVCIHKDETDLLFTD | 1346 | P51587 | |
| LILAELLHVCDTAFE | 476 | P19525 | |
| DCFVLEDEGLHTIAA | 281 | Q9UJT9 | |
| ELFEIEIDTLETTCH | 76 | P02765 | |
| VEDVLELHCEALRGS | 221 | Q96LA6 | |
| GDVLTFLDSHVECNV | 581 | Q7Z7M9 | |
| ECLIIAHSVGVESLF | 321 | Q5XKL5 | |
| NHVSDLGLVLCDFED | 1306 | O75417 | |
| GRDLTDFLENVLTCH | 2571 | P12111 | |
| FEALSELIILTASHC | 201 | Q16850 | |
| ESESKDHFLIACDLL | 61 | Q5VVM6 | |
| ELTVFSLIVVDECHH | 121 | Q96C10 | |
| LVEELFLGDIHTDAT | 226 | Q8J025 | |
| TVEDGLLTVECKLDH | 286 | O60381 | |
| EDVSEVLAHIGTCLR | 101 | Q5VZK9 | |
| VHILGCEVSEEEFRE | 56 | Q8TE02 | |
| VIFSSCGDLDLLEHQ | 2416 | Q5TBA9 | |
| CGDLDLLEHQTSLVS | 2421 | Q5TBA9 | |
| CSTDLFVELADHLLD | 206 | O75155 | |
| LTHVTLFECEEGDPD | 336 | Q9UJW0 | |
| EELLCSAEATLALHT | 361 | Q6PJW8 | |
| DETEFCGEELLHSVL | 186 | Q8N1G2 | |
| RELDIEVFSILHCGL | 926 | Q9BXW9 | |
| LFESCHETSECLELA | 166 | A0A1B0GVS7 | |
| FEHEELTVSQLLLCL | 226 | Q96CV9 | |
| LLSELFLSVHFEDCG | 261 | Q6NXP6 | |
| HCEIDIASDGDVTLT | 491 | Q9H1H9 | |
| DETCLFESEGLVLHK | 126 | O43903 | |
| SGVEVHLDCESIFVI | 416 | Q9P2F6 | |
| SLIFHEDCSVVTEVG | 931 | Q86VV8 | |
| SVIIELVDDHFEGSL | 381 | Q8NCE0 | |
| LVDFLTGEEVVCHVA | 156 | Q9H9J2 | |
| TEEVSLFLELCFKIH | 16 | Q9BXW3 | |
| DGLETEKCLHVVTEA | 81 | Q96KG9 | |
| ADLCGHSLALLEDLE | 41 | Q5HYW2 | |
| FSEIDVDNLGHITLC | 276 | Q9UPR0 | |
| DLEILHYVVDGIDCL | 76 | A3QJZ6 | |
| LDGDECLSHEEFLGV | 376 | Q8IYU8 | |
| LELQVHLGDEGEFTC | 306 | Q9Y286 | |
| VTAALELCEEVHLFG | 306 | O15466 | |
| HLHFDVELLGDCDVI | 471 | Q96EB6 | |
| VVLATHLCDEVSLAG | 346 | Q9UNP4 | |
| GLDDTLHTIIDYACE | 706 | Q96T21 | |
| VAACEGHLSTVEFLL | 1151 | Q9C0D5 | |
| LVIEEAERSIHDALC | 396 | P50991 | |
| DHICSTEAEGELLQL | 636 | Q8TE82 | |
| GITLIAVDEAHCISE | 661 | Q14191 | |
| ILGSDDATTCHIVVL | 66 | Q96AB6 | |
| HRICLALESIISEEE | 776 | O00444 | |
| HPLVGSCFEDLAEEL | 276 | Q07889 | |
| TDTVFENCGHLTELE | 361 | Q15399 | |
| VNEHTEEGESLLCLA | 231 | Q8IWZ3 | |
| FIGSHVIELDDCVQT | 226 | Q2KHT3 | |
| CTDGSSFVEEVERHL | 1501 | O75094 | |
| ILENDITGVLDHTFC | 536 | Q9HAU4 | |
| DICDSHFVKLLFETE | 76 | O95455 | |
| EEHVTCVQSILDEFL | 311 | Q9H4L4 | |
| EDCELSSHFADISLI | 586 | Q6AWC2 | |
| SSLCSIDEEHLTDIE | 381 | Q6GYQ0 | |
| TDVQFIAVTGDHECL | 276 | O95210 | |
| EGCLTTHSSIADLEE | 826 | Q76I76 | |
| HSLVLDCGAISFLDV | 656 | O43511 | |
| VHELDTTGECLVDLG | 326 | Q96N76 | |
| HAIFVITIECSEVGL | 216 | O15066 | |
| LHSGEELVCKVFDIS | 81 | Q92519 | |
| DLSHEAILLACESTD | 491 | O75717 | |
| LQGSSEHTEIICDLI | 111 | Q6ZSR6 | |
| EHIPHDLFTELDEIC | 111 | Q6U841 | |
| EDYIVEIEILATCDH | 76 | O94804 | |
| DKLHCEDIGEDTVLV | 1176 | Q6ZT07 | |
| VAFCTHDLESLVGIT | 411 | Q8NE00 | |
| HLTLEFLEECISGFS | 1921 | P21359 | |
| CTLLHKSERAEEEGV | 96 | Q6AHZ1 | |
| EDLIDLCELTVTGHF | 766 | Q8TEA7 | |
| GQEHEGCLLLTSEVL | 3881 | Q7Z7G8 | |
| CEEIEGEHLPFLTSV | 581 | Q86YA3 | |
| TSIAILCEEFPHELG | 336 | Q9C0K1 | |
| EVLCLHLIESGNLTD | 241 | Q6PGP7 | |
| AEVEEGSCTLHLEAL | 686 | P52746 | |
| GSCTLHLEALGVELE | 691 | P52746 | |
| AVDDSESLRCEELHL | 1371 | Q70CQ2 | |
| TACHVTGDLVELLSI | 2986 | Q70CQ2 | |
| EHVILGTGELYLDCV | 626 | Q15029 | |
| CLLESELEAQLGEFH | 196 | Q6ZS17 | |
| EHDLVDDDITTGCLS | 1091 | Q9Y4E6 | |
| RGILEEEIINHSSCE | 56 | Q96FV9 | |
| ALFEHCSEVTEIFEL | 91 | Q9NR11 |